Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

2018 Korean Liver Cancer Association–National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma
KLCA Korean Liver Cancer Association, NCC National Cancer Center
Gut and Liver (2019) Vol. 13, Iss. 3, pp. 227-299
Open Access | Times Cited: 349

Showing 26-50 of 349 citing articles:

Clinical practice guideline and real-life practice in hepatocellular carcinoma: A Korean perspective
Myung Ji Goh, Dong Hyun Sinn, Jong Man Kim, et al.
Clinical and Molecular Hepatology (2023) Vol. 29, Iss. 2, pp. 197-205
Open Access | Times Cited: 22
Correlation and efficacy of TACE combined with lenvatinib plus PD‐1 inhibitor in the treatment of hepatocellular carcinoma with portal vein tumor thrombus based on immunological features
Xinhua Zou, Qingyu Xu, Ran You, et al.
Cancer Medicine (2023) Vol. 12, Iss. 10, pp. 11315-11333
Open Access | Times Cited: 22
Substantial risk of recurrence even after 5 recurrence-free years in early-stage hepatocellular carcinoma patients
Jihye Kim, Wonseok Kang, Dong Hyun Sinn, et al.
Clinical and Molecular Hepatology (2020) Vol. 26, Iss. 4, pp. 516-528
Open Access | Times Cited: 55
Switching to systemic therapy after locoregional treatment failure: Definition and best timing
Sadahisa Ogasawara, Yoshihiko Ooka, Keisuke Koroki, et al.
Clinical and Molecular Hepatology (2020) Vol. 26, Iss. 2, pp. 155-162
Open Access | Times Cited: 53
Exosomal microRNA‐4661‐5p–based serum panel as a potential diagnostic biomarker for early‐stage hepatocellular carcinoma
Hyo Jung Cho, Geum Ok Baek, Chul Won Seo, et al.
Cancer Medicine (2020) Vol. 9, Iss. 15, pp. 5459-5472
Open Access | Times Cited: 53
LI-RADS treatment response categorization on gadoxetic acid-enhanced MRI: diagnostic performance compared to mRECIST and added value of ancillary features
Se Woo Kim, Ijin Joo, Hyo‐Cheol Kim, et al.
European Radiology (2020) Vol. 30, Iss. 5, pp. 2861-2870
Closed Access | Times Cited: 52
Comparison of LI-RADS 2018 and KLCA-NCC 2018 for noninvasive diagnosis of hepatocellular carcinoma using magnetic resonance imaging
Sunyoung Lee, Seung‐seob Kim, Dong Ryul Chang, et al.
Clinical and Molecular Hepatology (2020) Vol. 26, Iss. 3, pp. 340-351
Open Access | Times Cited: 50
Laparoscopic Liver Resection versus Percutaneous Radiofrequency Ablation for Small Single Nodular Hepatocellular Carcinoma: Comparison of Treatment Outcomes
Dong Ho Lee, Jing Woong Kim, Jeong Min Lee, et al.
Liver Cancer (2021) Vol. 10, Iss. 1, pp. 25-37
Open Access | Times Cited: 50
Multimarker Panels for Detection of Early Stage Hepatocellular Carcinoma: A Prospective, Multicenter, Case‐Control Study
Teerha Piratvisuth, Tawesak Tanwandee, Satawat Thongsawat, et al.
Hepatology Communications (2021) Vol. 6, Iss. 4, pp. 679-691
Open Access | Times Cited: 47
Prognosis and treatment pattern of advanced hepatocellular carcinoma after failure of first-line atezolizumab and bevacizumab treatment
Ching-Tso Chen, Yin‐Hsun Feng, Chia‐Jui Yen, et al.
Hepatology International (2022) Vol. 16, Iss. 5, pp. 1199-1207
Closed Access | Times Cited: 36
Hepatocellular carcinoma incidence is decreasing in Korea but increasing in the very elderly
Young Eun Chon, Sung Yong Park, Hanpyo Hong, et al.
Clinical and Molecular Hepatology (2022) Vol. 29, Iss. 1, pp. 120-134
Open Access | Times Cited: 34
Variant Hepatocellular Carcinoma Subtypes According to the 2019 WHO Classification: An Imaging-Focused Review
Liang Meng Loy, Hsien Min Low, Jin‐Young Choi, et al.
American Journal of Roentgenology (2022) Vol. 219, Iss. 2, pp. 212-223
Closed Access | Times Cited: 32
Comparison of radiofrequency ablation and ablative external radiotherapy for the treatment of intrahepatic malignancies: A hybrid meta-analysis
Chai Hong Rim, Jung Sue Lee, Soo‐Yeon Kim, et al.
JHEP Reports (2022) Vol. 5, Iss. 1, pp. 100594-100594
Open Access | Times Cited: 32
Hepatitis B Virus Treatment and Hepatocellular Carcinoma: Controversies and Approaches to Consensus
Soo Ki Kim, Takako Fujii, Soo Ryang Kim, et al.
Liver Cancer (2022) Vol. 11, Iss. 6, pp. 497-510
Open Access | Times Cited: 29
Real-World Data on the Diagnosis, Treatment, and Management of Hepatocellular Carcinoma in the Asia-Pacific: The INSIGHT Study
Yu Ki Sim, Ming Chuen Chong, Mihir Gandhi, et al.
Liver Cancer (2023) Vol. 13, Iss. 3, pp. 306-321
Open Access | Times Cited: 17
The Burden of Hepatocellular Carcinoma in Non-Alcoholic Fatty Liver Disease: Screening Issue and Future Perspectives
Grazia Pennisi, Ciro Celsa, Antonina Giammanco, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 22, pp. 5613-5613
Open Access | Times Cited: 47
Comparison of diagnostic performance of non-contrast MRI and abbreviated MRI using gadoxetic acid in initially diagnosed hepatocellular carcinoma patients: a simulation study of surveillance for hepatocellular carcinomas
Sunyoung Whang, Moon Hyung Choi, Joon‐Il Choi, et al.
European Radiology (2020) Vol. 30, Iss. 8, pp. 4150-4163
Closed Access | Times Cited: 41
Incorporating sarcopenia and inflammation with radiation therapy in patients with hepatocellular carcinoma treated with nivolumab
Nalee Kim, Jeong Il Yu, Hee Chul Park, et al.
Cancer Immunology Immunotherapy (2020) Vol. 70, Iss. 6, pp. 1593-1603
Closed Access | Times Cited: 40
Noncontrast MRI for Hepatocellular Carcinoma Detection: A Systematic Review and Meta-analysis – A Potential Surveillance Tool?
Michael Chan, Ya Ruth Huo, Nelson Trieu, et al.
Clinical Gastroenterology and Hepatology (2021) Vol. 20, Iss. 1, pp. 44-56.e2
Open Access | Times Cited: 37
Sonazoid-enhanced ultrasonography: comparison with CT/MRI Liver Imaging Reporting and Data System in patients with suspected hepatocellular carcinoma
Jeong Ah Hwang, Woo Kyoung Jeong, Ji Hye Min, et al.
ULTRASONOGRAPHY (2021) Vol. 40, Iss. 4, pp. 486-498
Open Access | Times Cited: 36
Treatments of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: Current Status and Controversy
Zhu‐Jian Deng, Le Li, Yu‐Xian Teng, et al.
Journal of Clinical and Translational Hepatology (2021) Vol. 10, Iss. 1, pp. 147-158
Open Access | Times Cited: 35
Efficacy and Safety of Lenvatinib Combined With PD-1 Inhibitors Plus TACE for Unresectable Hepatocellular Carcinoma Patients in China Real-World
Xiaowei Li, Zhigang Fu, Xiaoxia Chen, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 27
Prognostic significance of cachexia index in patients with advanced hepatocellular carcinoma treated with systemic chemotherapy
Myung Ji Goh, Wonseok Kang, Woo Kyoung Jeong, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 23
Overview of the immunological mechanisms in hepatitis B virus reactivation: Implications for disease progression and management strategies
Hui Ma, Qing-Zhu Yan, Jingru Ma, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 10, pp. 1295-1312
Open Access | Times Cited: 5
Comparison of MicroFlow Imaging with color and power Doppler imaging for detecting and characterizing blood flow signals in hepatocellular carcinoma
Jae Seok Bae, Jeong Min Lee, Sun Kyung Jeon, et al.
ULTRASONOGRAPHY (2019) Vol. 39, Iss. 1, pp. 85-93
Open Access | Times Cited: 42

Scroll to top